Artelo biosciences, inc. reports earnings results for the full year ended august 31, 2019

Artelo biosciences, inc. announced earnings results for the full year ended august 31, 2019. for the full year, the company announced operating loss was usd 3.209 million compared to usd 2.343 million a year ago. net loss was usd 2.172 million compared to usd 2.343 million a year ago. basic loss per share was usd 1 compared to usd 1.84 a year ago. diluted loss per share was usd 1.46 compared to usd 1.84 a year ago.
ARTL Ratings Summary
ARTL Quant Ranking